---
figid: PMC8829728__10.1177_24705470221076390-fig3
figtitle: Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation
organisms:
- Escherichia coli
- Nicotiana tabacum
- Candida dubliniensis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Porphyromonas gingivalis
- Zingiber officinale
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Sus scrofa
- Homo sapiens
- gut metagenome
- prion
pmcid: PMC8829728
filename: 10.1177_24705470221076390-fig3.jpg
figlink: /pmc/articles/PMC8829728/figure/fig3-24705470221076390/
number: F3
caption: Intracellular sensing of LPS and the non-canonical inflammasome. (1) Binding
  of PAMPs such as LPS to extracellular pattern-recognition receptors activates signal
  transduction cascades that induce gene expression of the components required for
  non-canonical inflammasome activation, a process termed “priming”. (2) Extracellular
  Gram-negative bacteria or their outer membrane vesicles (OMVs) can deliver LPS into
  the cytoplasm of host cells through endocytosis. (3) Guanylate-binding proteins
  (GBP) together with IRGB10 disrupt vacuoles containing pathogens, which enables
  LPS to be released into the cytosol. (*) LPS from OMVs are released from early endosomes,
  which does not involve GBPs/IRGB10 mediated lysis. (4) HMGB1 promotes the internalisation
  of LPS into vacuoles through RAGE. (5) HMGB1 additionally permeabilises this vacuole
  to release LPS into the cytosol. Cytosolic LPS can be recognised by inflammatory
  caspases and to provide a “triggering” signal for activation of the non-canonical
  inflammasome pathway. (6) The lipid A tail of LPS binds to the CARD motif of pro-caspase
  4 in a direct interaction. (7) These intracellular LPS–pro-caspase 4 complexes dimerise
  and (8) oligomerise through the CARD motif, and proximity-induced activation leads
  to a catalytically active conformation of the non-canonical inflammasome. (9) The
  activated non-canonical inflammasome cleaves gasdermin D (GSDMD), releasing the
  amino-terminal fragments, (10) which form pores at the cell membrane. (11) The non-canonical
  inflammasome also activates the NLRP3 canonical inflammasome through an unknown
  mechanism, (12) and this inflammasome pathway releases IL-1β and IL-18, which is
  secreted through GSDMD pores. (13) LPS can additionally be delivered into cells
  through cell-bound LBP. (14) Intracellular transport of LPS by LBP raises the possibility
  of a role for LBP in the delivery of LPS to intracellular LPS receptors such as
  endosomal TLR4 and inflammatory caspases.
papertitle: The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation.
reftext: Martin J. Page, et al. Chronic Stress (Thousand Oaks). 2022 Jan-Dec;6:24705470221076390.
year: '2022'
doi: 10.1177/24705470221076390
journal_title: Chronic Stress
journal_nlm_ta: Chronic Stress (Thousand Oaks)
publisher_name: SAGE Publications
keywords: lipopolysaccharide | coagulation | chronic inflammation | immunopatholgy
  | noncommunicable diseases
automl_pathway: 0.9295253
figid_alias: PMC8829728__F3
figtype: Figure
organisms_ner:
- Sus scrofa
- Homo sapiens
- Rattus norvegicus
- Oryctolagus cuniculus
- Mus musculus
redirect_from: /figures/PMC8829728__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8829728__10.1177_24705470221076390-fig3.html
  '@type': Dataset
  description: Intracellular sensing of LPS and the non-canonical inflammasome. (1)
    Binding of PAMPs such as LPS to extracellular pattern-recognition receptors activates
    signal transduction cascades that induce gene expression of the components required
    for non-canonical inflammasome activation, a process termed “priming”. (2) Extracellular
    Gram-negative bacteria or their outer membrane vesicles (OMVs) can deliver LPS
    into the cytoplasm of host cells through endocytosis. (3) Guanylate-binding proteins
    (GBP) together with IRGB10 disrupt vacuoles containing pathogens, which enables
    LPS to be released into the cytosol. (*) LPS from OMVs are released from early
    endosomes, which does not involve GBPs/IRGB10 mediated lysis. (4) HMGB1 promotes
    the internalisation of LPS into vacuoles through RAGE. (5) HMGB1 additionally
    permeabilises this vacuole to release LPS into the cytosol. Cytosolic LPS can
    be recognised by inflammatory caspases and to provide a “triggering” signal for
    activation of the non-canonical inflammasome pathway. (6) The lipid A tail of
    LPS binds to the CARD motif of pro-caspase 4 in a direct interaction. (7) These
    intracellular LPS–pro-caspase 4 complexes dimerise and (8) oligomerise through
    the CARD motif, and proximity-induced activation leads to a catalytically active
    conformation of the non-canonical inflammasome. (9) The activated non-canonical
    inflammasome cleaves gasdermin D (GSDMD), releasing the amino-terminal fragments,
    (10) which form pores at the cell membrane. (11) The non-canonical inflammasome
    also activates the NLRP3 canonical inflammasome through an unknown mechanism,
    (12) and this inflammasome pathway releases IL-1β and IL-18, which is secreted
    through GSDMD pores. (13) LPS can additionally be delivered into cells through
    cell-bound LBP. (14) Intracellular transport of LPS by LBP raises the possibility
    of a role for LBP in the delivery of LPS to intracellular LPS receptors such as
    endosomal TLR4 and inflammatory caspases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LBP
  - IL1B2
  - IL18
  - HMGB1
  - AGER
  - MOK
  - NLRP3
  - GSDMD
  - TLR4
  - EHHADH
  - RPSA
  - IRF6
  - IL1B
  - Lbp
  - Ehhadh
  - Il1b
  - Il18
  - Hmgb1
  - Hbp1
  - Ager
  - Mok
  - Nlrp3
  - Gsdmd
  - Tlr4
  - Gm12250
---
